GlaxoSmithKline

Page 2 of 5

Female CEOs run 7% of companies on the Coins2Day 500 Europe, from H&M to Chanel
Newsletters

Female CEOs run 7% of companies on the Coins2Day 500 Europe, from H&M to Chanel

By Emma Hinchliffe and Joey Abrams
November 9, 2023
GSK’s CEO says you need thick skin if you’re going to step into the C-suite
Leadership

Digital Assets Editor

By
May 31, 2023
Cityscape mixed with green plants, multi layered image
Newsletters

Being ‘nature-positive’ has been a hollow aim. That’s about to change

By
May 25, 2023
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
Finance

The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021

By
August 15, 2022
US-HEALTH-VIRUS-TREATMENT
Health

GSK says its COVID antibody therapy works against Omicron. Here’s what other drugmakers say about their treatments

By
December 7, 2021
In this photo illustration the Covax Facility logo seen displayed on a smartphone screen with the logo of CureVac in the background.
Health

CureVac scraps its first-generation COVID-19 vaccine candidate, shares tumble

By
October 12, 2021
Glaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s
Health

Glaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s

By Suzi Ring and Bloomberg
July 2, 2021
An employee checks bottles of diluent inside the pharmaceutical plant Fareva in Poce-sur-Cisse, Central France, on April 22, 2021. Fareva was chosen as the main supplier of the candidate RNA messenger vaccine from the German company CureVac. The site will therefore produce the diluent used in this vaccine.
Health

These four COVID-19 vaccines could soon join the pandemic fight

By
May 8, 2021
GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment
Leadership

GlaxoSmithKline gets rid of Trump’s vaccine adviser Slaoui for sexual harassment

By James Paton, Riley Griffin and Bloomberg
March 24, 2021
Promising COVID-19 antibody therapy significantly reduces risk of hospitalization, death
Health

Promising COVID-19 antibody therapy significantly reduces risk of hospitalization, death

By Suzi Ring and Bloomberg
March 12, 2021
Sanofi and GSK to restart trial of COVID-19 vaccine after delay
Health

Sanofi and GSK to restart trial of COVID-19 vaccine after delay

By Tim Loh, Suzi Ring and Bloomberg
February 22, 2021
In this photo illustration various medical syringes seen with Sanofi Pasteur company logo displayed on a screen in the background.
Health

GSK and Sanofi shares fall as the pharma giants delay COVID-19 vaccine until late 2021

By
December 11, 2020
Sanofi, GlaxoSmithKline reach multi-billion dollar deal with U.S. for coronavirus vaccine
Newsletters

Sanofi, GlaxoSmithKline reach multi-billion dollar deal with U.S. for coronavirus vaccine

By
July 31, 2020
U.S. pledges $2.1 billion for up to 600 million doses of Sanofi, GlaxoSmithKline vaccine
Health

U.S. pledges $2.1 billion for up to 600 million doses of Sanofi, GlaxoSmithKline vaccine

By James Paton and Bloomberg
July 31, 2020
Sanofi will combine its experimental coronavirus vaccine with GlaxoSmithKline Plc’s adjuvant technology, which may allow more doses of a shot to be produced.
Health

Digital Assets Editor

By James Paton, Suzi Ring and Bloomberg
April 14, 2020

Most Popular